Bookmark
Forward
Adavosertib Is Safe and Efficacious in CCNE1-Amplified Solid Tumors.
Cancer discovery 2023 Feb 06Sizes of these terms reflect their relevance to your search.
Adavosertib shows safety and promising antitumor efficacy in advanced CCNE1-amplified solid tumors. ©2023 American Association for Cancer Research.
Citation
Adavosertib Is Safe and Efficacious in CCNE1-Amplified Solid Tumors. Cancer discovery. 2023 Feb 06;13(2):257
Mesh Tags
Substances
PMID: 36524815
View Full Text
